BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders: some common and contrasting features.
Cross
N C P
NC
Daley
G Q
GQ
Green
A R
AR
Hughes
T P
TP
Jamieson
C
C
Manley
P
P
Mughal
T
T
Perrotti
D
D
Radich
J
J
Skoda
R
R
Soverini
S
S
Vainchenker
W
W
Verstovsek
S
S
Villeval
J-L
JL
Goldman
J M
JM
D002908:Chronic Disease; D002986:Clinical Trials as Topic; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D042822:Genomic Instability; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics / Q000378:metabolism; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D009196:Myeloproliferative Disorders / Q000235:genetics* / Q000473:pathology / Q000628:therapy
D016044:Fusion Proteins, bcr-abl; C507924:JAK2 protein, human; D053614:Janus Kinase 2